Comparison of the effect of bupivacaine injection alone and in association with dexmedetomidine on pain and complications after inguinal hernia surgery

Phase 3

Recruiting

Conditions: R10.2
Pelvic and perineal pain
Transversus abdominis plane (TAP) block with ultrasound guidance on pain and complications after inguinal hernia surgery.

Registration Number: IRCT20121216011766N5

Lead Sponsor: Rasht University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 66

Inclusion Criteria

18 to 65 years old
Body mass index 35-18 kilogram / meter 2
Lack of drug sensitivity
No alcohol and drug addiction
Type of surgery including restoration without tension with mesh
ASA class I,II

Exclusion Criteria

Surgery lasts more than 2 hours
Need for concurrent surgery during inguinal hernia surgery
Need to get opium in recovery room
excessive hemorrhage
Recurrence of hernia
Need for spinal anesthesia

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparing the effect of injecting Bupivacaine alone and in association with dexmedetomidine through Transversus Abdominis Plane(TAP) Block with ultrasound guidance in pain and complications after inguinal hernia surgery. Timepoint: In the recovery unit (at 0 o'clock) and at 2, 4, 6, 12, 24 hours after surgery, pain intensity will be measured in the two groups with visual analogue scale (VAS). Method of measurement: In this way, people are asked to show their pain intensity on a 10 cm ruler. no pain will be scored as zero and score 10 is for the highest pain.

Secondary Outcome Measures

Name	Time	Method
In 24 hours after surgery that patients are hospitalized in ward , they will be prescribed 0.5 milligram/kilogram of pethidine, if they need painkillers and they state VAS> 3. Also, complications such as nausea, dizziness and vomiting, the first dose and the mean dose of pethidine consumed in the two groups will be investigated. Timepoint: In the recovery unit (at 0 o'clock) and at 2, 4, 6, 12, 24 hours after surgery. Method of measurement: Nausea, dizziness and vomiting.